Barlow Carrolee
Reporting owner on Forms 3, 4 and 5, CIK 1745316.
Barlow Carrolee reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| SUPNCIK 1356576 | director | 1 | 2026-11-04 |
| Supernus, Inc. CIK 1625297 | director | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Supernus, Inc. Common Stock | 2026-11-02 | J other | +41,652 | $0 | 41,652 | Form 4 |
| Supernus, Inc. Restricted Stock Units, derivative | 2026-11-02 | J other | +4,603 | $0 | 4,603 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +15,729 | $0 | 15,729 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +19,138 | $0 | 19,138 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +14,330 | $0 | 14,330 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +11,342 | $0 | 11,342 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +10,545 | $0 | 10,545 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +9,691 | $0 | 9,691 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +12,708 | $0 | 12,708 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +11,236 | $0 | 11,236 | Form 4 |
| Supernus, Inc. Director Stock Option (right to buy), derivative | 2026-11-02 | J other | +7,665 | $0 | 7,665 | Form 4 |
| SUPN · CIK 1356576Common Stock | 2026-11-02 | J other | -27,045 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Restricted Stock Unit, derivative | 2026-11-02 | J other | -2,989 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -10,213 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -12,427 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -9,305 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -7,365 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -6,847 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -6,293 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -8,252 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -7,296 | $0 | 0 | Form 4 |
| SUPN · CIK 1356576Director Stock Option (Right to Buy), derivative | 2026-11-02 | J other | -4,977 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001104659-26-122838 | Supernus, Inc. | 2026-11-04 | ||
| Form 4 0001745316-26-000006 | SUPERNUS PHARMACEUTICALS, INC. | 2026-11-04 | ||
| Form 3 0001104659-26-122717 | Supernus, Inc. | 2026-11-04 |